Federal agencies will no longer be required to get SBOMs from tech vendors, nor attestations of compliance with NIST's ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

Investing.com -- Unicycive Therapeutics (NASDAQ:UNCY) stock rose 3% Thursday morning after the company announced that the U.S ...

Wizz Air’s Chief Financial Officer has downplayed the airline’s application for US flights, and ruled out the launch of ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that the U.S. Food & Drug ...

FDA assigns Prescription Drug User Fee Act (PDUFA) target date of June 29, 2026Ended 2025 with unaudited cash position of $41 ...

The man has lived in the country for a decade and was married to a U.S. citizen while the government processed his ...

FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening MENLO PARK, Calif., Jan. 29, 2026 /PRNewswire/ ...

Unicycive Therapeutics (UNCY) stock gains as the resubmitted marketing application for the kidney disease drug undergoes FDA review. Read more here.

FDA approvals, trial progress and early commercial momentum put several ASX healthcare companies in a strong position heading ...

A New Orleans Police Department recruit detained this week by federal Immigration and Customs Enforcement agents is a Cameroonian man who has lived in the country for a decade and ...

In 2018, Shenzhen Kinghelm Electronics Co., Ltd. was granted an invention patent for its Beidou-Based Intelligent ...